Abbrea Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $377K | Sell |
2,639
-647
| -20% | -$92.4K | 0.05% | 178 |
|
|
2024
Q1 | $425K | Hold |
3,286
| – | – | 0.06% | 184 |
|
|
2023
Q4 | $340K | Sell |
3,286
-150
| -4% | -$15.5K | 0.05% | 195 |
|
|
2023
Q3 | $312K | Buy |
3,436
+152
| +5% | +$13.8K | 0.05% | 190 |
|
|
2023
Q2 | $266K | Sell |
3,284
-100
| -3% | -$8.1K | 0.04% | 204 |
|
|
2023
Q1 | $271K | Hold |
3,384
| – | – | 0.05% | 199 |
|
|
2022
Q4 | $229K | Buy |
+3,384
| New | +$229K | 0.04% | 212 |
|
|
2022
Q3 | – | Sell |
-3,614
| Closed | -$201K | – | 221 |
|
|
2022
Q2 | $201K | Hold |
3,614
| – | – | 0.03% | 226 |
|
|
2022
Q1 | $203K | Hold |
3,614
| – | – | 0.03% | 237 |
|
|
2021
Q4 | $202K | Buy |
+3,614
| New | +$202K | 0.03% | 247 |
|